DECLARATION DE CONFORMITE CE CE DECLARATION OF CONFORMITY

Similar documents
This document is a preview generated by EVS

The Regulation of medical devices in the European Union

This document is a preview generated by EVS

ISO INTERNATIONAL STANDARD

ISO INTERNATIONAL STANDARD

COMMISSION OF THE EUROPEAN COMMUNITIES. Proposal for a REGULATION OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL

USER S GUIDE DECLARATION «CE» DE CONFORMITE «EC» DECLARATION OF CONFORMITY. NUM AXES déclare que / declares that

Quality of Veterinary Medicinal Products. How to ensure the quality of Veterinary Medicinal Products

Commercial imports into the Union of dogs, cats and ferrets

Quality of Veterinary Medicinal Products. How to ensure the quality of Veterinary Medicinal Products

Annex to the Accreditation Certificate D-K according to DIN EN ISO/IEC 17025:2005

New Zealand - bovine tuberculosis equivalence STANDING COMMITTEE ON PLANTS, ANIMALS, FOOD AND FEED 5-6MARCH 2015

Bovine Brucellosis Control of indirect ELISA kits

Recognition of Export Controls and Certification Systems for Animals and Animal Products. Guidance for Competent Authorities of Exporting Countries

Applied-for scope of designation and notification of a Conformity Assessment Body Regulation (EU) 2017/746 (IVDR)

L 210/36 Official Journal of the European Union DECISIONS COMMISSION

SILAB For Africa a LIMS for African Country and Animal Identification Registration Traceability system

ANNEX Part 1 Model animal health certificate for imports into the Union of dogs, cats and ferrets COUNTRY:

ANNEXES. to the Proposal. for a REGULATION OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL

NASH Analysis Lab. Report of the audit. Prepared by: NASH Analysis Lab. CEO: Ni Ni Win. Quality manager: AgnieszkaPaszkowska

LA GAZETTE. October 2014 FOCUS ON DELEGATE INTERVIEW. Looking for a puppy? LET S GO to

Inheritance of coat and colour in the Griffon Bruxellois dog

CATS POWER CALIBRATOR BPP

Organic food. Ingredients coming from organic source FOR CATS AND DOGS. equilibre-et-instinct.com Offering the best for your pet

DG(SANCO)/ MR

80 Million Birds: Reducing songbird mortality through cat owner engagement

International movement of pet animals

Dr Dooshima Kwange Department of Veterinary and Pest Control Services FMARD

Ministry of Climate Change & Environment (MOCCAE) Model of Veterinary Health Certificate for Exporting Cats and Dogs to the UAE

HEALTH REGULATIONS RELATED TO ANIMALS ADMISSION TO THE EUROPEAN HOLSTEIN CHAMPIONSHIP IN COLMAR, FRANCE, FROM 14 TO 19 JUNE 2016

The Honourable Jane Philpott Minister of Health (Canada) Via RE: Antimicrobial Resistance

Import Health Standard

DIGITUS Network Cabinet Unique Series, 600, 800 mm width - 600, 800, 1000, 1200 mm depth

I.3. Central competent authority. Local competent authority I.6. I.12. I.16. Entry BIP in EU. I.17. No(s) of CITES. I.22. Number of packages

ISO INTERNATIONAL STANDARD

COMMISSION IMPLEMENTING DECISION

THE IMPORTANCE OF QUALITY IN COMPOUNDED VETERINARY MEDICINES

OIE International Standards. Scientific and Technical Department

Better Training for Safer Food

The OIE Relevant Standards and Guidelines for Veterinary Medicinal Products

Transmitted by Co-Chairs of the Informal Working Party On Periodical Technical Inspections. WP (08-11 March 2016, agenda item 7.

Central competent authority. Local competent authority. I.16. Entry BIP in EU. I.17. No.(s) of CITES

Management of antimicrobial resistance in animals in Belgium : Measures in veterinary medicine in the One Health context

Dr Elisabeth Erlacher-Vindel Head of Science and New Technologies Department Achievements and future perspectives

Sales survey of Veterinary Medicinal Products containing Antimicrobials in France

ANNUAL STATISTICAL REPORT FOR ANIMALS USED IN IRELAND UNDER SCIENTIFIC ANIMAL PROTECTION LEGISLATION

The European Union Reference Laboratories network

GAPFA PET FOOD SAFETY GUIDANCE. PFAC, Niagara-on-the-Lake 2 November 2017

Istituto G. Caporale. 17/05/2011 Istituto G. Caporale Teramo 1

Pigeon Spike Plastic Narrow Bird Spikes Includes specs for: Pigeon Spike Plastic Narrow Bird Spike and Surface Cleaning Systems.

Pigeon Spike Composite Bird Spikes Includes specifications for: Pigeon Spike Composite Bird Spike and Surface Cleaning Systems.

Herbal Medicine for Animal Use in JAPAN

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1/12

Legislation, Registration and Control Procedures for Veterinary Medicinal Products in the European Union

Overview of the OIE PVS Pathway

Canadian Standards of Care in Animal Shelters: Supporting ASV Guidelines

Neglected Zoonoses Situation (Philippines) EMELINDA L. LOPEZ, DVM, MSc Animal Health and Welfare Division Bureau of Animal Industry

Antimicrobial Resistance, yes we care! The European Joint Action

FRENCH AGENCY FOR VETERINARY MEDICINAL PRODUCTS La Haute Marche Javené BP FOUGERES cedex FRANCE

Operating Instruction EHP Issue 09/2016

Working group session

INFLUENCE OF CONTAMINATION OF ENVIRONMENT AND BREEDING CONDITIONS ON DEVELOPMENT OF COCCIDIOSIS IN CHICKENS

INFECTION PREVENTION SILVER ANTI-MICROBIAL TEXTILES

RESOLUTION: BE IT RESOLVED AND ORDAINED That the City of Shelton adopt the Vicious Dogs "Gracie's Law" Ordinance as follows following Ordinance:

Official Journal of the European Union. (Acts whose publication is obligatory)

This document is meant purely as a documentation tool and the institutions do not assume any liability for its contents

Air Receivers TECHNOLOGY YOU CAN TRUST

LIFE.2.B EUROPEAN UNION. Brussels, 14 November 2018 (OR. en) 2014/0255 (COD) PE-CONS 43/18 AGRILEG 102 VETER 52 CODEC 1149

AHFA 2016 Regulatory Summit. Antimicrobial Material Preservatives & Sustainability Considerations

KREISEL Rotary valve vs. screw pump

Electromagnetic flowmeters. dg: NEW. Sensors MUT 2200 EL / MUT 2500 EL DS100-4-ENG 1/14

2016/LSIF/FOR/004 Policies to Promote Patient Access to Innovative Treatments and Combat Antimicrobial Resistance

2016 No. 58 ANIMALS. The Microchipping of Dogs (Scotland) Regulations 2016

Background 1 st, 2 nd and 3 rd FAO-APHCA/OIE Regional Workshop on Brucellosis Diagnosis and Control with an Emphasis on Brucella melitensis (in

ULTRAVIOL. UltraViol is a dynamically developing. We invite you to become our business partner.

OIE Standards on Veterinary Legislation: Chapter 3.4 of the OIE Terrestrial Animal Health Code

AMOXICILLIN AND CLAVULANIC ACID TABLETS Draft proposal for The International Pharmacopoeia (February 2018)

Agency Profile. At A Glance

Sales survey of veterinary medicinal products containing antimicrobials in France in Annual report

TABLE 1: NUMBER OF ANIMALS USED IN RELATION TO THEIR PLACE OF ORIGIN

MATERIAL SAFETY DATA SHEET

Overseas Market Access Requirements Notification - Animal Products Act 1999

DIRECTIVE 2001/82/EC OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL of 6 November 2001 on the Community code relating to veterinary medicinal products

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

SIngle use. Recreating harmonious bodies for a new vision of rebirth.

Sales survey of Veterinary Medicinal Products containing Antimicrobials in France Volumes and estimated exposure of animals to antimicrobials

DRAFT UGANDA STANDARD

Outline of Risk Analysis for Veterinary Vaccines in Japan

(2) Active non-implantable devices for imaging, monitoring and/or diagnosis

United Kingdom Veterinary Medicines Directorate Woodham Lane New Haw Addlestone Surrey KT15 3LS DECENTRALISED PROCEDURE

They're not all the same: Why FDA approval of animal drugs matters

Breeding aims to develop sheep milk production

Cost of National Wildlife Rabies Eradication Programmes. Dr. Hans-Joachim Bätza

[Version 8, 10/2012] SUMMARY OF PRODUCT CHARACTERISTICS

in food safety Jean-Luc ANGOT CVO France

CHAPTER 3.3. VETERINARY LEGISLATION

Council of the European Union Brussels, 15 September 2014 (OR. en) Mr Uwe CORSEPIUS, Secretary-General of the Council of the European Union

The benefits of I&R for cats and dogs EU Parliament - Strasbourg 8 September Dr. Paolo Dalla Villa

REPORT FROM THE COMMISSION TO THE EUROPEAN PARLIAMENT AND THE COUNCIL. on systems restraining bovine animals by inversion or any unnatural position

COMMISSION IMPLEMENTING REGULATION (EU)

Transcription:

DECLARATION DE CONFORMITE CE CE DECLARATION OF CONFORMITY NOUS LE FABRICANT WE THE MANUFACTURER SFRI Sarl Lieu dit Berganton 33127 St Jean d'illac France DECLARONS QUE LES PRODUITS DECLARE THAT THE PRODUCTS A0208 - COUNTENDER 20+ GMDN CODE : 35479 SONT CONFORMES AUX DIRECTIVES ET NORMES CONFORM TO DIRECTIVES AND STANDARDS Regular Dispositions : European Directive 98/79/CE dated 27 October 1998 (annexes I and III) European Directive 89/336/CEE dated 3 may 1989, modified by European directive 93/68/CEE dated 22 July 1993 European Directive 73/23/CEE Standards IEC 61010 1 : 1990 + A1 : 1992 + A2 : 1995 EN 61000 3 2 EN 61000 3 3 Made in St Jean d'illac, France On the 6 th of April, 2011 Mr Jacques HOEFMAN Co Chief Executive Office DCCE GB C20+ 2011 04 SFRI Sarl Lieu dit Berganton 33127 Saint Jean d Illac France Téléphone +33 (0)5 56 68 80 50 Télécopieur +33 (0)5 56 21 79 03 contact@sfri.com Sarl au Capital de 75000 Euros RCS Bordeaux 453 866 824 (2004 B 01622) No SIRET 453 866 824 00015 TVA CEE : FR 38 453 866 824

DECLARATION DE CONFORMITE CE CE DECLARATION OF CONFORMITY NOUS LE FABRICANT WE THE MANUFACTURER SFRI Sarl Lieu dit Berganton 33127 St Jean d'illac France DECLARONS QUE LES PRODUITS DECLARE THAT THE PRODUCTS BloodCal, codes R021003, R021004 SONT CONFORMES AUX DIRECTIVES ET NORMES CONFORM TO DIRECTIVES AND STANDARDS 98/79/EEC IVD medical devices Annex III EN 375:2001 Information supplied by the manufacturer with in vitro diagnostic reagents for professional use EN 12286:1998 In vitro diagnostic medical devices Measurement of quantities in samples of biological origin Presentation of reference measurement procedures EN 12287:1999 In vitro diagnostic medical devices Measurement of quantities in samples of biological origin Description of reference materials EN ISO 13485:2003 Medical devices Quality management systems Requirements for regulatory purposes EN 13612:2002 Performance evaluation of in vitro diagnostic medical devices EN 13640:2002 Stability testing of in vitro diagnostic reagents EN 13641:2002 Elimination or reduction of risk of infection related to in vitro diagnostic reagents EN 13975:2003 Sampling procedures used for acceptance testing of in vitro diagnostic medical devices Statistical aspects EN ISO 14971:2007 Medical devices Application of risk management to medical devices EN ISO 17511:2003 In vitro diagnostic medical devices Measurement of quantities in biological samples Metrological traceability of values assigned to calibrators and control materials Made in St Jean d'illac, France On the 12 th of Novembre, 2009 Mr Jacques HOEFMAN Co Chief Executive Officer DCCE GB BlooTrol 16 2009 11 SFRI Sarl Lieu dit Berganton 33127 Saint Jean d Illac France Téléphone +33 (0)5 56 68 80 50 Télécopieur +33 (0)5 56 21 79 03 contact@sfri.com Sarl au Capital de 75000 Euros RCS Bordeaux 453 866 824 (2004 B 01622) No SIRET 453 866 824 00015 TVA CEE : FR 38 453 866 824

DECLARATION DE CONFORMITE CE CE DECLARATION OF CONFORMITY NOUS LE FABRICANT WE THE MANUFACTURER SFRI Sarl Lieu dit Berganton 33127 St Jean d'illac France DECLARONS QUE LES PRODUITS DECLARE THAT THE PRODUCTS BloodTrol 16, codes R021001, R021002, R021005, R021006 SONT CONFORMES AUX DIRECTIVES ET NORMES CONFORM TO DIRECTIVES AND STANDARDS 98/79/EEC IVD medical devices Annex III EN 375:2001 Information supplied by the manufacturer with in vitro diagnostic reagents for professional use EN 12286:1998 In vitro diagnostic medical devices Measurement of quantities in samples of biological origin Presentation of reference measurement procedures EN 12287:1999 In vitro diagnostic medical devices Measurement of quantities in samples of biological origin Description of reference materials EN ISO 13485:2003 Medical devices Quality management systems Requirements for regulatory purposes EN 13612:2002 Performance evaluation of in vitro diagnostic medical devices EN 13640:2002 Stability testing of in vitro diagnostic reagents EN 13641:2002 Elimination or reduction of risk of infection related to in vitro diagnostic reagents EN 13975:2003 Sampling procedures used for acceptance testing of in vitro diagnostic medical devices Statistical aspects EN ISO 14971:2007 Medical devices Application of risk management to medical devices EN ISO 17511:2003 In vitro diagnostic medical devices Measurement of quantities in biological samples Metrological traceability of values assigned to calibrators and control materials Made in St Jean d'illac, France On the 12 th of Novembre, 2009 Mr Jacques HOEFMAN Co Chief Executive Officer DCCE GB BlooTrol 16 2009 11 SFRI Sarl Lieu dit Berganton 33127 Saint Jean d Illac France Téléphone +33 (0)5 56 68 80 50 Télécopieur +33 (0)5 56 21 79 03 contact@sfri.com Sarl au Capital de 75000 Euros RCS Bordeaux 453 866 824 (2004 B 01622) No SIRET 453 866 824 00015 TVA CEE : FR 38 453 866 824